Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics … Read more
Quest Diagnostics Incorporated (DGX) - Total Liabilities
Latest total liabilities as of December 2025: $8.94 Billion USD
Based on the latest financial reports, Quest Diagnostics Incorporated (DGX) has total liabilities worth $8.94 Billion USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Quest Diagnostics Incorporated - Total Liabilities Trend (1996–2025)
This chart illustrates how Quest Diagnostics Incorporated's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Quest Diagnostics Incorporated Competitors by Total Liabilities
The table below lists competitors of Quest Diagnostics Incorporated ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
The Procter & Gamble Company
SA:PGCO34
|
Brazil | R$74.25 Billion |
|
Estee Lauder Companies Inc
NYSE:EL
|
USA | $15.60 Billion |
|
Woodward Inc
NASDAQ:WWD
|
USA | $2.15 Billion |
|
Regions Financial Corporation
NYSE:RF
|
USA | $140.45 Billion |
|
AIB Group plc
PINK:AIBGY
|
USA | $129.99 Billion |
|
Constellation Brands Inc Class A
NYSE:STZ
|
USA | $13.68 Billion |
|
Telefonaktiebolaget LM Ericsson Class B
PINK:ERIXF
|
USA | $168.54 Billion |
|
Oriental Land Co. Ltd
PINK:OLCLF
|
USA | $511.72 Billion |
Liability Composition Analysis (1996–2025)
This chart breaks down Quest Diagnostics Incorporated's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.04 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.18 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.25 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Quest Diagnostics Incorporated's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Quest Diagnostics Incorporated (1996–2025)
The table below shows the annual total liabilities of Quest Diagnostics Incorporated from 1996 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $8.94 Billion | -3.44% |
| 2024-12-31 | $9.26 Billion | +21.74% |
| 2023-12-31 | $7.60 Billion | +11.33% |
| 2022-12-31 | $6.83 Billion | -3.11% |
| 2021-12-31 | $7.05 Billion | -1.21% |
| 2020-12-31 | $7.13 Billion | +0.78% |
| 2019-12-31 | $7.08 Billion | +25.11% |
| 2018-12-31 | $5.66 Billion | +3.49% |
| 2017-12-31 | $5.47 Billion | +1.96% |
| 2016-12-31 | $5.36 Billion | +3.55% |
| 2015-12-31 | $5.18 Billion | -6.63% |
| 2014-12-31 | $5.55 Billion | +11.50% |
| 2013-12-31 | $4.97 Billion | -2.41% |
| 2012-12-31 | $5.10 Billion | -8.94% |
| 2011-12-31 | $5.60 Billion | +25.14% |
| 2010-12-31 | $4.47 Billion | -1.73% |
| 2009-12-31 | $4.55 Billion | -5.14% |
| 2008-12-31 | $4.80 Billion | -8.44% |
| 2007-12-31 | $5.24 Billion | +98.37% |
| 2006-12-31 | $2.64 Billion | +3.90% |
| 2005-12-31 | $2.54 Billion | +32.79% |
| 2004-12-31 | $1.92 Billion | +0.44% |
| 2003-12-31 | $1.91 Billion | +22.59% |
| 2002-12-31 | $1.56 Billion | -2.46% |
| 2001-12-31 | $1.59 Billion | -13.00% |
| 2000-12-31 | $1.83 Billion | -9.06% |
| 1999-12-31 | $2.02 Billion | +154.37% |
| 1998-12-31 | $792.30 Million | -7.79% |
| 1997-12-31 | $859.20 Million | +0.33% |
| 1996-12-31 | $856.35 Million | -- |